GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tesaro Inc (NAS:TSRO) » Definitions » Total Inventories

Tesaro (Tesaro) Total Inventories : $108.8 Mil (As of Sep. 2018)


View and export this data going back to 2012. Start your Free Trial

What is Tesaro Total Inventories?

Tesaro's total inventories for the quarter that ended in Sep. 2018 was $108.8 Mil. Tesaro's average total inventories from the quarter that ended in Jun. 2018 to the quarter that ended in Sep. 2018 was $98.1 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Tesaro's Net-Net Working Capital per share for the quarter that ended in Sep. 2018 was $-5.21.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Tesaro's Days Inventory for the three months ended in Sep. 2018 was 598.74.

Inventory Turnover measures how fast the company turns over its inventory within a year. Tesaro's Inventory Turnover for the quarter that ended in Sep. 2018 was 0.15.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Tesaro's Inventory-to-Revenue for the quarter that ended in Sep. 2018 was 1.52.


Tesaro Total Inventories Historical Data

The historical data trend for Tesaro's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tesaro Total Inventories Chart

Tesaro Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Total Inventories
Get a 7-Day Free Trial - - 1.11 14.70 57.94

Tesaro Quarterly Data
Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18
Total Inventories Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 50.53 57.94 74.44 87.41 108.82

Tesaro Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.


Tesaro  (NAS:TSRO) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Tesaro's Net-Net Working Capital Per Share for the quarter that ended in Sep. 2018 is

Net-Net Working Capital Per Share (Q: Sep. 2018 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(476.812+0.75 * 31.362+0.5 * 108.822-841.632
-0-0)/55.035
=-5.21

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Tesaro's Days Inventory for the three months ended in Sep. 2018 is calculated as:

Days Inventory=Average Total Inventories (Q: Sep. 2018 )/Cost of Goods Sold (Q: Sep. 2018 )*Days in Period
=98.114/14.953*365 / 4
=598.74

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Tesaro's Inventory Turnover for the quarter that ended in Sep. 2018 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Sep. 2018 ) / Average Total Inventories (Q: Sep. 2018 )
=14.953 / 98.114
=0.15

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Tesaro's Inventory to Revenue for the quarter that ended in Sep. 2018 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Sep. 2018 ) / Revenue (Q: Sep. 2018 )
=98.114 / 64.399
=1.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.


Tesaro Total Inventories Related Terms

Thank you for viewing the detailed overview of Tesaro's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.


Tesaro (Tesaro) Business Description

Traded in Other Exchanges
N/A
Address
Tesaro is an oncology-focused biopharmaceutical company with a focus on developing treatments for cancer. Upon successful development and regulatory approval of any of its product candidates, the company intends to pursue commercialization in key product markets, including North America, Europe, and China. Tesaro is currently focused on commercializing products directly in North America, and directly or in partnership with established companies in Europe and China. The company's strategy is to identify, acquire, and develop promising drug candidates, and to commercialize cancer therapeutics that are potentially safer and more effective than existing treatments.
Executives
Mary Lynne Hedley director, officer: President & COO C/O TESARO, INC., 1000 WINTER ST., STE 3300, WALTHAM MA 02451
Kavita Patel director C/O TESARO, INC., 1000 WINTER STREET, SUITE 3300, WALTHAM MA 02451
Huber Martin H. Jr. officer: SVP & Chief Medical Officer C/O TESARO, INC., 1000 WINTER STREET, SUITE 3300, WALTHAM MA 02451
Moulder Leon O Jr director, officer: Chief Executive Officer C/O TESARO, INC., 1000 WINTER STREET, SUITE 3300, WALTHAM MA 02451
James O Armitage director C/O TESARO, INC., 1000 WINTER ST., SUITE 3300, WALTHAM MA 02451
Timothy R Pearson officer: Exec. VP, CFO C/O TESARO, INC., 1000 WINTER STREET, SUITE 3300, WALTHAM MA 02451
Garry A Nicholson director C/O TESARO, INC., 1000 WINTER STREET, SUITE 3300, WALTHAM MA 02451
Grant C. Bogle officer: Sr. VP, Chief Commercial Ofc C/O TESARO, INC. 1000 WINTER STREET, SUITE 3300 WALTHAM MA 02451
Nea Partners 13, Limited Partnership 10 percent owner 1119 ST. PAUL STREET, BALTIMORE MD 21202
Nea 13 Gp, Ltd 10 percent owner 1119 ST. PAUL STREET, BALTIMORE MD 21202
New Enterprise Associates 13 Lp 10 percent owner 1119 ST PAUL STREET, BALTIMORE MD 21202
Collier Earl M Jr director C/O TESARO, INC., 1000 WINTER STREET, SUITE 3300, WALTHAM MA 02451
Beth C Seidenberg director
Joseph L Farmer officer: Sr VP, Gen Counsel & Secretary C/O TESARO, INC. 1000 WINTER STREET, SUITE 3300 WALTHAM MA 02451
Patrick J Kerins 10 percent owner

Tesaro (Tesaro) Headlines

From GuruFocus